Lower neutrophil‐to‐lymphocyte ratio and positive programmed cell death ligand‐1 expression are favorable prognostic markers in patients treated with pembrolizumab for urothelial carcinoma

BACKGROUND: Immune checkpoint inhibitors (ICIs) are effective in some cancer patients; however, they may show no efficacy in others. Predictive biomarkers are crucial for appropriately selecting the patients who receive ICI therapy. This study aimed to clarify the predictors of disease progression i...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyama, Yu, Kaneko, Go, Nishimoto, Koshiro, Yasuda, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678108/
https://www.ncbi.nlm.nih.gov/pubmed/35699000
http://dx.doi.org/10.1002/cam4.4779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678108/
https://www.ncbi.nlm.nih.gov/pubmed/35699000
http://dx.doi.org/10.1002/cam4.4779

Ejemplares similares